TIMELINE OF ASSESSMENT
The table below shows the Timeline for Major Applications – General HTA track.
| HEALTH TECHNOLOGY | LAPATINIB FOR HER2(+) BC | TACE WITH MITOMYCIN C | ZOLEDRONIC ACID | CEREBROLYSIN | INSULIN ANALOGUES | NEW OHA (DPP4 AND SGLT2 INHIBITORS: Sitagliptin and Dapagliflozin) | DEXAMETHASONE IMPLANT | DIRECT ORAL ANTICOAGULANTS | CITICOLINE | TIROFIBAN | TICAGRELOR (90 MG) | IVABRADINE |
| PROPONENT | PSVIR | NKTI | SSP | PSEDM | PSEDM | PAO | PNA | PNA | PSCCI | PHC | PHA | |
| TOPIC NOMINATION | 19 February 2019 | 08 February 2019 | 08 November 2018 | 24 January 2017 | 07 September 2016 | July 2018 | 31 January 2019 | 31 January 2019 | 30 January 2019 | 31 January 2019 | ||
| TOPIC PRIORITIZATION | ||||||||||||
| SCOPING | -present | 07 May 2021 - present | 31 March 2021 - 14 April 2021 | 11 May 2021 - present | 11 May 2021 - present | |||||||
| PROTOCOL DEVELOPMENT | 15 April 2021 - 21 May 2021 | |||||||||||
| CLINICAL ASSESSMENT | 21 May 2021 Present | 30 March 2021 - 30 May 2021 | ||||||||||
| ECONOMIC ASSESSMENT | 31 May 2021 - present | |||||||||||
| EVIDENCE APPRAISAL | ||||||||||||
| RECOMMENDATION | 07 May 2021 - present | |||||||||||
| APPEALS | ||||||||||||
| RESOLUTION | ||||||||||||
| DECISION | ||||||||||||
| DISSEMINATION |